New drug combo aims to shrink bladder tumors before surgery
Disease control
Recruiting now
This study tests a drug called erdafitinib, alone or with another drug (cetrelimab), given before surgery to people with muscle-invasive bladder cancer whose tumors have certain gene changes (FGFR). The goal is to see if these drugs can shrink or eliminate the cancer before the b…
Phase: PHASE2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated May 17, 2026 01:50 UTC